Literature DB >> 670998

Serum dopamine-beta-hydroxylase in schizophrenic patients.

K Fujita, T Ito, K Maruta, R Teradaira, H Beppu, Y Nakagami, Y Kato, T Nagatsu, T Kato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 670998     DOI： 10.1111/j.1471-4159.1978.tb10494.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  4 in total

1.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

Review 2.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

3.  Altered interrelationship of dopamine, prolactin, thyrotropin and thyroid hormone in schizophrenic patients.

Authors:  M L Rao; G Gross; G Huber
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

4.  Psychological effects of dopamine beta-hydroxylase inhibition: a failure to replicate.

Authors:  E Hartmann; M Oldfield; S Adelman; R Edelberg
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.